Cerus Gross Margin 2010-2025 | CERS

Current and historical gross margin for Cerus (CERS) over the last 10 years. The current gross profit margin for Cerus as of March 31, 2025 is %.
Cerus Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.21B $0.13B 60.10%
2024-12-31 $0.20B $0.12B 59.41%
2024-09-30 $0.20B $0.12B 60.61%
2024-06-30 $0.19B $0.12B 60.82%
2024-03-31 $0.19B $0.12B 61.78%
2023-12-31 $0.19B $0.12B 62.90%
2023-09-30 $0.18B $0.12B 63.04%
2023-06-30 $0.18B $0.12B 63.39%
2023-03-31 $0.18B $0.11B 62.30%
2022-12-31 $0.19B $0.11B 60.64%
2022-09-30 $0.19B $0.11B 60.43%
2022-06-30 $0.18B $0.11B 59.56%
2022-03-31 $0.17B $0.10B 59.54%
2021-12-31 $0.16B $0.10B 60.00%
2021-09-30 $0.14B $0.09B 59.72%
2021-06-30 $0.13B $0.08B 60.31%
2021-03-31 $0.12B $0.07B 61.67%
2020-12-31 $0.12B $0.07B 62.61%
2020-09-30 $0.11B $0.07B 63.55%
2020-06-30 $0.10B $0.07B 64.36%
2020-03-31 $0.10B $0.06B 64.58%
2019-12-31 $0.09B $0.06B 64.52%
2019-09-30 $0.09B $0.06B 63.22%
2019-06-30 $0.08B $0.05B 61.45%
2019-03-31 $0.08B $0.05B 61.25%
2018-12-31 $0.08B $0.05B 60.00%
2018-09-30 $0.07B $0.04B 56.76%
2018-06-30 $0.07B $0.04B 57.35%
2018-03-31 $0.06B $0.03B 56.67%
2017-12-31 $0.05B $0.03B 56.86%
2017-09-30 $0.04B $0.03B 59.09%
2017-06-30 $0.04B $0.02B 56.10%
2017-03-31 $0.04B $0.02B 51.28%
2016-12-31 $0.04B $0.02B 46.15%
2016-09-30 $0.04B $0.02B 40.54%
2016-06-30 $0.04B $0.01B 34.29%
2016-03-31 $0.04B $0.01B 28.57%
2015-12-31 $0.04B $0.01B 28.57%
2015-09-30 $0.04B $0.01B 28.57%
2015-06-30 $0.04B $0.01B 35.14%
2015-03-31 $0.04B $0.02B 40.54%
2014-12-31 $0.04B $0.02B 43.24%
2014-09-30 $0.04B $0.02B 47.22%
2014-06-30 $0.04B $0.02B 43.24%
2014-03-31 $0.04B $0.02B 42.11%
2013-12-31 $0.04B $0.02B 42.50%
2013-09-30 $0.04B $0.02B 42.86%
2013-06-30 $0.04B $0.02B 46.15%
2013-03-31 $0.04B $0.02B 47.37%
2012-12-31 $0.04B $0.02B 43.24%
2012-09-30 $0.04B $0.02B 41.67%
2012-06-30 $0.04B $0.02B 43.24%
2012-03-31 $0.04B $0.02B 42.86%
2011-12-31 $0.03B $0.02B 45.45%
2011-09-30 $0.03B $0.01B 48.28%
2011-06-30 $0.03B $0.01B 48.00%
2011-03-31 $0.02B $0.01B 50.00%
2010-12-31 $0.02B $0.01B 52.17%
2010-09-30 $0.02B $0.01B 50.00%
2010-06-30 $0.02B $0.01B 40.91%
2010-03-31 $0.02B $0.01B 40.00%
2009-12-31 $0.02B $0.01B 35.29%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.271B $0.180B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Boston Scientific (BSX) United States $147.057B 36.81
Stryker (SYK) United States $145.454B 30.41
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.264B 21.80
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
LeMaitre Vascular (LMAT) United States $1.878B 41.99
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.606B 5.03
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.09
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00